Cardiff University | Prifysgol Caerdydd ORCA
Online Research @ Cardiff 
WelshClear Cookie - decide language by browser settings

Browse by Current Cardiff authors

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Number of items: 6.

Alhadj Ali, M., Gee, N.Tze, Howell, A., Stenson, R. and Dayan, C. 2017. Factors influencing effective recruitment to phase 1 interventional trials in new-onset type 1 diabetes: analysis of 12 months referrals to diabetes research centre [Abstract]. Diabetic Medicine 34 (S1) , P122. 10.1111/dme.16_13304

Gillespie, David, Farewell, Daniel, Barrett-Lee, Peter, Casbard, Angela, Hawthorne, Anthony Barney, Hurt, Christopher, Murray, Nick, Probert, Chris, Stenson, Rachel and Hood, Kerenza 2017. The use of randomisation-based efficacy estimators in non-inferiority trials. Trials 18 (1) , 117. 10.1186/s13063-017-1837-3
file

Alhadj Ali, M., Bowen-Morris, J., Gee, N. Tze, Stenson, R., Walkey, H., Littlemore, K. and Dayan, C. 2017. Use of a “YouTube” style video clip to raise interest amongst young people with new‐onset Type 1 diabetes in immunotherapy trials [Abstract]. Diabetic Medicine 34 (S1) , P315. 10.1111/dme.24_13304

Gillespie, David, Hood, Kerenza, Farewell, Daniel, Hawthorne, Antony, Hurt, Chris Nicholas, Probert, Chris, Stenson, Rachel, Barrett-Lee, Peter, Casbard, Angela C. and Murray, Nick 2015. The use of randomisation-based efficacy estimators in non-inferiority trials [Poster Presentation]. Trials 16 (Suppl) , P129. 10.1186/1745-6215-16-S2-P129
file

Gillespie, David, Hood, Kerenza, Farewell, Daniel, Stenson, Rachel, Probert, Christopher and Hawthorne, A. Barney 2014. Electronic monitoring of medication adherence in a 1-year clinical study of 2 dosing regimens of mesalazine for adults in remission with ulcerative colitis. Inflammatory Bowel Diseases 20 (1) , pp. 82-91. 10.1097/01.MIB.0000437500.60546.2a

Hawthorne, A. B., Stenson, Rachel, Gillespie, David, Swarbrick, Edwin T., Dhar, Anjan, Kapur, Kapil C., Hood, Kerenza and Probert, Chris S. J. 2012. One-year investigator-blind randomized multicenter trial comparing asacol 2.4 g once daily with 800 mg three times daily for maintenance of remission in ulcerative colitis. Inflammatory Bowel Diseases 18 (10) , pp. 1885-1893. 10.1002/ibd.21938

This list was generated on Sat Nov 28 04:10:10 2020 GMT.